Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRANSIBELA: Transient Belatacept in Kidney Transplant
NCT04013620Phase 3Unknown
- Sponsor
- CHU de Nantes
- Start
- Sep 2020
- Primary completion
- Jul 2022
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of belatacept in chronic kidney disease (CKD), sponsored by CHU de Nantes. Status: unknown.
02
Drugs
belatacept
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT04013620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04013620.